Generic Drugs – Pharmacy News – Drug Store News, generic drug company.#Generic #drug #company

Posted On Jan 19 2018 by

Generic Drugs & Pharmacy News FDA approves Glenmark’s generic Hailey Fe 1/20 The contraceptive had U.S. brand and generic sales of roughly $116.8 million, according to data from IQVIA for the 12 months ended September 2017. Ajanta launches generic Kapvay FDA approves Cipla’s generic Pulmicort Respules Q s bread and butter and the years to come hold a lot of promise. Biosimilars poised to bring savings — if they get to launch Even as more approvals roll in and industry officials talk about how biosimilars will bring significant savings in the coming decade, there is a concern that regulatory and …


States target Mylan – s president in generic drug pricing probe – Chicago Tribune, generic drug company.#Generic #drug #company

Posted On Jan 19 2018 by

States target Mylan’s president in generic drug pricing probe Mylan’s headquarters is seen July 14, 2014 in Canonsburg, Pa. Forty-five state attorneys general conducting a multiyear probe into alleged price collusion by makers of generic drugs is seeking to add Mylan to their lawsuit. Mylan’s headquarters is seen July 14, 2014 in Canonsburg, Pa. Forty-five state attorneys general conducting a multiyear probe into alleged price collusion by makers of generic drugs is seeking to add Mylan to their lawsuit. (Jeff Swensen / Getty Images) Mylan’s second-ranking executive was named in a civil investigation by dozens of states conducting a multiyear …


Generic drug company, generic drug company.#Generic #drug #company

Posted On Jan 19 2018 by

YahooNews FILE PHOTO: Mylan NL CEO Heather Bresch is sworn in before a House Oversight and Government Reform Committee hearing in Washington By Karen Freifeld WASHINGTON (Reuters) – A large group of U.S. states accused key players in the generic drug industry of a broad price-fixing conspiracy, moving on Tuesday to widen an earlier lawsuit to add many more drugmakers and medicines in an action that sent some company shares tumbling. The lawsuit, brought by the attorneys general of 45 states and the District of Columbia, accused 18 companies and subsidiaries and named 15 medicines. It also targeted two individual …


20 States Accuse Generic Drug Companies of Price Fixing, generic pharma companies.#Generic #pharma #companies

Posted On Jan 18 2018 by

The New York Times A wide-ranging investigation into generic drug prices took its most significant turn yet on Thursday, as state attorneys general accused two industry leaders, Teva Pharmaceuticals and Mylan, and four smaller companies of engaging in brazen price-fixing schemes — and promised that more charges were coming. A civil complaint filed by 20 states accuses the companies of conspiring to artificially inflate prices on an antibiotic and a diabetes drug, with executives coordinating through informal industry gatherings and personal calls and text messages. Officials said the case was a small example of broader problems in the drug business. …


SM Pharmaceuticals, generic pharmaceuticals companies.#Generic #pharmaceuticals #companies

Posted On Jan 18 2018 by

generic pharmaceuticals companies Principles S.M. PHARMACEUTICALS takes action in the pharmaceutical market on generic and innovative products, as a new, rising and promising company, creating continuously complete services witch supply even the most ad hoc needs. The co-operation with strong Greek pharmaceutical industries that possess ISO and GMPs, according to the European legislation, ensures the quality of production. Vision S.M. PHARMACEUTICALS wants and possesses the ability to officiate in the field of medicine, making its presence more significant and asserting with no influence its position among the strongest natively Greek pharmaceutical companies. Responsibility Trust, reliability, integrity and social service (CSR) …


HyGen Pharmaceuticals Inc, generic pharmaceuticals companies.#Generic #pharmaceuticals #companies

Posted On Jan 18 2018 by

Welcome HyGen Pharmaceuticals, Inc. is a leading independent wholesaler of prescription and specialty pharmaceuticals located in Redmond, Washington. The company was founded in 1993 with the goal of becoming a trusted partner to independent pharmacies, long term care facilities and mail order pharmacies across the nation. We offer a broad portfolio that includes generics, specialty products, controlled substances (CII’s – CV’s), over-the-counter products and medical supplies. We know that our customers face a lot of demands and challenges and we support them by proving modern technology and related services to deliver quality products to their customers. By working closely with …


Pharmaceutical Company in India, Ahmedabad, Pharma Company in India, Cadila Pharmaceuticals, generic pharmaceuticals companies.#Generic #pharmaceuticals #companies

Posted On Jan 18 2018 by

Formulations A wide array of more than 850 products to meet most unmet medical needs, catering to a vast and diverse therapeutic portfolio More than 38 APIs and intermediates including USFDA – certified products are manufactured at our ISO-9002 ISO14001 accredited facilities at Ankleshwar, India Innovation Innovative products like ‘Polycap’ for cardiovascular disease, Risorine for Tuberculosis and Mycidac –C for lung cancer have been developed inhouse Manufacturing Three state of the art manufacturing facilities in the state of Gujarat, Jammu (India) and Ethiopia are approved by all prominent international regulatory bodies, including USFDA About us Cadila Pharmaceuticals Limited, established in …


Pharma companies fight behind-the-scenes wars over generic drugs, generic drug companies.#Generic #drug #companies

Posted On Jan 18 2018 by

Pharma companies fight behind-the-scenes wars over generic drugs By Robin Feldman ll good things must come to an end” is a proverb that brand-name drug makers have trouble taking to heart. Just look at the strategies used to prevent competitors from bringing less-expensive generics to market. Pharmaceutical research has led to tremendous advances in medicine. Because of the extraordinarily high cost of bringing new drugs to the market, our intellectual property system is designed to ensure that drug companies recoup their investment and earn a profit. After a period of time, though, generic competitors are supposed to be able to …


Pharma companies fight behind-the-scenes wars over generic drugs, top generic drug companies.#Top #generic #drug #companies

Posted On Jan 17 2018 by

Pharma companies fight behind-the-scenes wars over generic drugs By Robin Feldman ll good things must come to an end” is a proverb that brand-name drug makers have trouble taking to heart. Just look at the strategies used to prevent competitors from bringing less-expensive generics to market. Pharmaceutical research has led to tremendous advances in medicine. Because of the extraordinarily high cost of bringing new drugs to the market, our intellectual property system is designed to ensure that drug companies recoup their investment and earn a profit. After a period of time, though, generic competitors are supposed to be able to …


Pharma companies fight behind-the-scenes wars over generic drugs, top generic drug companies.#Top #generic #drug #companies

Posted On Jan 17 2018 by

Pharma companies fight behind-the-scenes wars over generic drugs By Robin Feldman ll good things must come to an end” is a proverb that brand-name drug makers have trouble taking to heart. Just look at the strategies used to prevent competitors from bringing less-expensive generics to market. Pharmaceutical research has led to tremendous advances in medicine. Because of the extraordinarily high cost of bringing new drugs to the market, our intellectual property system is designed to ensure that drug companies recoup their investment and earn a profit. After a period of time, though, generic competitors are supposed to be able to …